IL81920A - Vaccines comprising an antigen and interferon-ypsilon and their preparation - Google Patents
Vaccines comprising an antigen and interferon-ypsilon and their preparationInfo
- Publication number
- IL81920A IL81920A IL81920A IL8192087A IL81920A IL 81920 A IL81920 A IL 81920A IL 81920 A IL81920 A IL 81920A IL 8192087 A IL8192087 A IL 8192087A IL 81920 A IL81920 A IL 81920A
- Authority
- IL
- Israel
- Prior art keywords
- ypsilon
- vaccines
- interferon
- antigen
- preparation
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868606559A GB8606559D0 (en) | 1986-03-17 | 1986-03-17 | Vaccines |
GB868606560A GB8606560D0 (en) | 1986-03-17 | 1986-03-17 | Vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
IL81920A0 IL81920A0 (en) | 1987-10-20 |
IL81920A true IL81920A (en) | 1991-12-12 |
Family
ID=26290503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL81920A IL81920A (en) | 1986-03-17 | 1987-03-17 | Vaccines comprising an antigen and interferon-ypsilon and their preparation |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0241725B1 (xx) |
JP (1) | JPH0832633B2 (xx) |
AU (1) | AU607130B2 (xx) |
CA (1) | CA1323302C (xx) |
DE (1) | DE3782960T2 (xx) |
DK (1) | DK175283B1 (xx) |
ES (1) | ES2052503T3 (xx) |
FI (1) | FI93423C (xx) |
GR (1) | GR3007080T3 (xx) |
IE (1) | IE59927B1 (xx) |
IL (1) | IL81920A (xx) |
NO (1) | NO871071L (xx) |
NZ (1) | NZ219631A (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820514A (en) * | 1985-12-30 | 1989-04-11 | Texas A&M University System | Low dosage of interferon to enhance vaccine efficiency |
WO1992004377A1 (en) * | 1990-08-31 | 1992-03-19 | Schering Corporation | HUMAN INTERFERON-η4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS |
ZA936095B (en) * | 1992-08-21 | 1994-03-14 | Univ Melbourne | Cytokine applications. |
GB9725480D0 (en) * | 1997-12-01 | 1998-01-28 | Univ London | Cytokines and their use in the treatment of established chronic infections and cancers |
AU2003268688A1 (en) * | 2002-09-30 | 2004-04-19 | Yamanouchi Pharmaceutical Co., Ltd. | Method of inducing immune responses |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0751511B2 (ja) * | 1982-03-15 | 1995-06-05 | 味の素株式会社 | インターロイキン2を含有してなる癌治療剤 |
US4820514A (en) * | 1985-12-30 | 1989-04-11 | Texas A&M University System | Low dosage of interferon to enhance vaccine efficiency |
US4938956A (en) * | 1987-04-01 | 1990-07-03 | International Minerals & Chemical Corp. | Synergistic immunostimulating composition and method |
-
1987
- 1987-03-14 EP EP87103717A patent/EP0241725B1/en not_active Expired - Lifetime
- 1987-03-14 ES ES87103717T patent/ES2052503T3/es not_active Expired - Lifetime
- 1987-03-14 DE DE8787103717T patent/DE3782960T2/de not_active Expired - Lifetime
- 1987-03-16 NO NO871071A patent/NO871071L/no unknown
- 1987-03-16 CA CA000532081A patent/CA1323302C/en not_active Expired - Lifetime
- 1987-03-16 DK DK198701332A patent/DK175283B1/da not_active IP Right Cessation
- 1987-03-16 IE IE68487A patent/IE59927B1/en not_active IP Right Cessation
- 1987-03-16 NZ NZ219631A patent/NZ219631A/xx unknown
- 1987-03-16 FI FI871131A patent/FI93423C/fi not_active IP Right Cessation
- 1987-03-17 IL IL81920A patent/IL81920A/xx not_active IP Right Cessation
- 1987-03-17 AU AU70086/87A patent/AU607130B2/en not_active Expired
- 1987-03-17 JP JP62062352A patent/JPH0832633B2/ja not_active Expired - Lifetime
-
1993
- 1993-02-17 GR GR930400313T patent/GR3007080T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IE870684L (en) | 1987-09-17 |
EP0241725A3 (en) | 1989-05-10 |
DK133287A (da) | 1987-09-18 |
EP0241725B1 (en) | 1992-12-09 |
AU607130B2 (en) | 1991-02-28 |
FI871131A0 (fi) | 1987-03-16 |
IL81920A0 (en) | 1987-10-20 |
DK133287D0 (da) | 1987-03-16 |
EP0241725A2 (en) | 1987-10-21 |
FI871131A (fi) | 1987-09-18 |
GR3007080T3 (xx) | 1993-07-30 |
JPH0832633B2 (ja) | 1996-03-29 |
CA1323302C (en) | 1993-10-19 |
NO871071L (no) | 1987-09-18 |
DE3782960D1 (de) | 1993-01-21 |
NO871071D0 (no) | 1987-03-16 |
FI93423C (fi) | 1995-04-10 |
AU7008687A (en) | 1987-09-24 |
DK175283B1 (da) | 2004-08-09 |
ES2052503T3 (es) | 1994-07-16 |
IE59927B1 (en) | 1994-05-04 |
NZ219631A (en) | 1990-03-27 |
JPS62277328A (ja) | 1987-12-02 |
DE3782960T2 (de) | 1993-04-29 |
FI93423B (fi) | 1994-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR900300069T1 (en) | Nanbv diagnostics and vaccines | |
IL68749A (en) | Modified antigens,their preparation and vaccines containing them | |
GB8907914D0 (en) | Vaccine preparation | |
IL80073A0 (en) | Vaccines and immunoassays for acquired immune deficiency syndrome(aids) | |
EP0157899A3 (en) | Multivalent pneumococcal vaccine and preparation thereof | |
EP0256878A3 (en) | Vaccines | |
EP0283505A4 (en) | VACCINE AND PRODUCTION METHOD. | |
IL82235A (en) | Immunogen complexes, their preparation and vaccines comprising them | |
GB2231053B (en) | Polylactones and their preparation | |
GB8702691D0 (en) | Vaccines | |
EP0467972A4 (en) | Rickettsial antigens for vaccination and diagnosis | |
IL81920A (en) | Vaccines comprising an antigen and interferon-ypsilon and their preparation | |
ZA874847B (en) | Oncornavirus vaccines | |
DE3760806D1 (en) | Monohalogenotrifluorooxetane and its preparation | |
NZ224862A (en) | Taenia ovis antigens and vaccines | |
GB8615068D0 (en) | Vaccines | |
GB2194235B (en) | Dichlorotrifluoromethyltoluenes and preparation thereof | |
GB2200638B (en) | Babesia divergens antigen and vaccine | |
GB2248186B (en) | Preparation of vaccines | |
IL65920A0 (en) | Vaccine and its preparation | |
GR862115B (en) | Vaccine and preparation method thereof | |
GB8621081D0 (en) | Vaccines | |
ZA888669B (en) | Nanbv diagnostics and vaccines | |
IL88420A0 (en) | Nanbv diagnostics and vaccines | |
HRP940493B1 (en) | Nanbv diagnostics and vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |